T. Rowe Price Associates’s Oscar Health OSCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.6M | Sell |
680,364
-2,644,932
| -80% | -$56.7M | ﹤0.01% | 1037 |
|
|
2025
Q1 | $43.6M | Sell |
3,325,296
-1,419,606
| -30% | -$18.6M | 0.01% | 761 |
|
|
2024
Q4 | $63.8M | Sell |
4,744,902
-643,159
| -12% | -$8.64M | 0.01% | 675 |
|
|
2024
Q3 | $114M | Buy |
5,388,061
+431,626
| +9% | +$9.15M | 0.01% | 538 |
|
|
2024
Q2 | $78.4M | Buy |
4,956,435
+978,283
| +25% | +$15.5M | 0.01% | 600 |
|
|
2024
Q1 | $59.2M | Buy |
3,978,152
+2,409,160
| +154% | +$35.8M | 0.01% | 681 |
|
|
2023
Q4 | $14.4M | Buy |
1,568,992
+704,913
| +82% | +$6.45M | ﹤0.01% | 1025 |
|
|
2023
Q3 | $4.81M | Buy |
864,079
+813,456
| +1,607% | +$4.53M | ﹤0.01% | 1187 |
|
|
2023
Q2 | $409K | Buy |
50,623
+5,601
| +12% | +$45.3K | ﹤0.01% | 2221 |
|
|
2023
Q1 | $295K | Buy |
45,022
+1,651
| +4% | +$10.8K | ﹤0.01% | 2351 |
|
|
2022
Q4 | $107K | Sell |
43,371
-90,735
| -68% | -$224K | ﹤0.01% | 2704 |
|
|
2022
Q3 | $670K | Sell |
134,106
-288,226
| -68% | -$1.44M | ﹤0.01% | 1973 |
|
|
2022
Q2 | $1.8M | Buy |
422,332
+292,016
| +224% | +$1.24M | ﹤0.01% | 1646 |
|
|
2022
Q1 | $1.3M | Buy |
130,316
+2,000
| +2% | +$19.9K | ﹤0.01% | 1864 |
|
|
2021
Q4 | $1.01M | Sell |
128,316
-24,828
| -16% | -$195K | ﹤0.01% | 2037 |
|
|
2021
Q3 | $2.66M | Sell |
153,144
-234,887
| -61% | -$4.08M | ﹤0.01% | 1627 |
|
|
2021
Q2 | $8.34M | Sell |
388,031
-113,632
| -23% | -$2.44M | ﹤0.01% | 1435 |
|
|
2021
Q1 | $13.5M | Buy |
+501,663
| New | +$13.5M | ﹤0.01% | 1343 |
|